Antioxidant protection against iron toxicity: Plasma changes during cardiopulmonary bypass in neonates, infants, and children

被引:4
作者
Mumby, S
Chaturvedi, R
Brierley, J
Lincoln, C
Petros, A
Redington, A
Gutteridge, JMC [1 ]
机构
[1] Royal Brompton & Harefield NHS Trsut, Directorate Anaesthesia & Crit Care, London SW3 6NP, England
[2] Royal Brompton & Harefield NHS Trsut, Dept Surg, London SW3 6NP, England
[3] Royal Brompton & Harefield NHS Trsut, Dept Paediat, London SW3 6NP, England
[4] Natl Heart & Lung Inst, London SW3 6NP, England
[5] Univ London Imperial Coll Sci Technol & Med, London, England
关键词
cardiopulmonary bypass; antioxidants; iron toxicity; reactive iron species; iron binding; iron oxidation; transferrin; caeruloplasmin;
D O I
10.1080/10715769900301651
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cardiopulmonary bypass surgery is associated with the release of low molecular mass iron, which increases the saturation of plasma transferrin to over 50% in all adult patients treated. In a significant minority, however plasma transferrin becomes 100% iron saturated and non-transferrin bound iron can be detected in the plasma. An iron-saturated transferrin is also a common physiological finding in normal term and pre-term infants at a time when their plasma antioxidants, which protect against iron toxicity and radical scavenging, are profoundly different from those seen in adults. This study was conducted to assess the extent to which antioxidants, which protect against iron toxicity, are altered in neonates, infants, and children undergoing cardiopulmonary bypass surgery.
引用
收藏
页码:141 / 148
页数:8
相关论文
共 21 条
[1]   The ferric reducing ability of plasma (FRAP) as a measure of ''antioxidant power'': The FRAP assay [J].
Benzie, IFF ;
Strain, JJ .
ANALYTICAL BIOCHEMISTRY, 1996, 239 (01) :70-76
[2]  
BULLEN JJ, 1987, MOL PHYSL CLIN ASPEC
[3]  
EVANS PJ, FEDERATION EUROPEAN, V303, P210
[4]   CERULOPLASMIN - PHYSIOLOGICAL AND PATHOLOGICAL PERSPECTIVES [J].
GUTTERIDGE, JMC ;
STOCKS, J .
CRC CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES, 1981, 14 (04) :257-329
[5]   INHIBITION OF LIPID-PEROXIDATION BY THE IRON-BINDING PROTEIN LACTOFERRIN [J].
GUTTERIDGE, JMC ;
PATERSON, SK ;
SEGAL, AW ;
HALLIWELL, B .
BIOCHEMICAL JOURNAL, 1981, 199 (01) :259-261
[6]  
GUTTERIDGE JMC, 1991, J TRACE ELEM ELECT H, V5, P279
[8]   ANTIOXIDANT PROTECTION AGAINST ORGANIC AND INORGANIC OXYGEN RADICALS BY NORMAL HUMAN PLASMA - THE IMPORTANT PRIMARY ROLE FOR IRON-BINDING AND IRON-OXIDIZING PROTEINS [J].
GUTTERIDGE, JMC ;
QUINLAN, GJ .
BIOCHIMICA ET BIOPHYSICA ACTA, 1993, 1156 (02) :144-150
[9]   Thiol-linked peroxidase activity of human ceruloplasmin [J].
Kim, IG ;
Park, SY ;
Kim, KC ;
Yum, JJ .
FEBS LETTERS, 1998, 431 (03) :473-475
[10]   LIMITED PROTECTION AGAINST IRON-INDUCED LIPID-PEROXIDATION BY CORD BLOOD-PLASMA [J].
LINDEMAN, JHN ;
HOUDKAMP, E ;
LENTJES, EGWM ;
POORTHUIS, BJHM ;
BERGER, HM .
FREE RADICAL RESEARCH COMMUNICATIONS, 1992, 16 (05) :285-294